India Piperacillin/Tazobactam Market to Grow at a Substantial Rate During the Forecast Period
Growing prevalence of
bacterial infections is expected to drive the growth of India
Piperacillin/Tazobactam market during the forecast period.
According to
TechSci Research report, “India
Piperacillin/Tazobactam Market By Route of Administration (Intravenous
injection v/s Intramuscular injection), By Distribution Channel (Online v/s
Offline), By Source (In-house v/s Contract Manufacturing Organizations), By
Application (Intra-abdominal infections, Nosocomial Pneumonia, Skin and Skin Structure
Infections, Community Acquired Pneumonia and Others), By End User (Adult v/s
Pediatric), By Company, By Region, Forecast & Opportunities, FY2027”, the India piperacillin/tazobactam market is expected to
grow at a substantial rate during the forecast period on account of its
suitability for the treatment of urinary tract infections. Piperacillin and tazobactam
injections are used for the treatment of appendicitis in adults and pediatric
patients, which in turn is expected to drive
the market growth during the forecast period. Additionally, uncomplicated as
well as complicated skin and skin structure infections, such as cellulitis,
ischemic/diabetic foot infections, etc. are known
to be well treated by this API drug which is projected to boost the growth of
India piperacillin/tazobactam Market. Also, side effects observed due to
consumption of piperacillin/tazobactam include headache, trouble sleeping,
rash, nausea, constipation, and diarrhea, among others, which can act as
impediment to the market growth over the coming years. Additionally, piperacillin/tazobactam
is suitable to treat intra-abdominal infections which is further estimated to
accelerate the market growth during the forecast period.
Browse XX market data Tables and XX
Figures spread through XXX Pages and an
in-depth TOC on "India
Piperacillin/Tazobactam Market"
https://www.techsciresearch.com/report/india-piperacillin-tazobactam-market/7296.html
The
India piperacillin/tazobactam market is segmented based on route of administration, distribution
channel, source, application, end user, company, and region. In terms of application, the
market is fragmented into intra-abdominal infections, nosocomial pneumonia,
skin and skin structure infections, community acquired pneumonia and others.
Out of which, the nosocomial pneumonia is expected to dominate the market in
the next 5 years which can be attributed to effectiveness of this drug in
treating nosocomial pneumonia. Based on route of administration, the market can
be segmented into intramuscular and intravenous. The intravenous route of
administration is expected to dominate the market in the coming years on
account of certain advantages it offers such rapid response, and easily control
over the dosage of the drug. Furthermore, intravenous route of administration
is much useful in situations of poor gastrointestinal absorption, which is
further forecast to contribute to the growth of the segment.
Aristo
Pharmaceuticals Ltd, Radicura Pharmaceuticals Pvt.
Ltd., Tauras Laboratories Pvt. Ltd., Taj Pharmaceuticals Ltd., Corona Remedies
Pvt. Ltd., Bestochem Formulations (India) Pvt. Ltd., Alpa Laboratories Ltd., Medical
Pharma Ltd., Cipla Ltd., Lupin Laboratories Ltd and others are some of the leading
players operating in India piperacillin/tazobactam market. Companies operating in the market are using organic
strategies such as product launches, mergers and acquisitions, research collaborations
to boost their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7296
Customers can also request for 10% free customization on this
report.
“India piperacillin/tazobactam
market is expected to witness substantial growth during the forecast period on
account of the rising initiatives by the government of the country for API
manufacturing and drug development. Additionally, piperacillin/tazobactam API is
used in intensive care medicine (pneumonia, peritonitis) which is further
expected to fuel the market growth through FY2027. Growing prevalence of skin
and tissue infections amongst population is forecast to bolster to demand for
piperacillin/tazobactam in the market over the next 5 years.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based global management consulting firm.
“India Piperacillin/Tazobactam Market By Route of
Administration (Intravenous injection v/s Intramuscular injection), By
Distribution Channel (Online v/s Offline), By Source (In-house v/s Contract
Manufacturing Organizations), By Application (Intra-abdominal Infections,
Nosocomial Pneumonia, Skin and Skin Structure Infections, Community Acquired Pneumonia
and Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast
& Opportunities, FY2027”, has evaluated
the future growth potential of India piperacillin/tazobactam market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in India piperacillin/tazobactam market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/